SQSTM1 mutations and glaucoma

PLoS ONE

Volumn 11, Issue 6, 2016, Pages

  Scheetz, Todd E ^a,b   Roos, Ben R ^a,b   Solivan Timpe, Frances ^a,b   Miller, Kathy ^a,b   Deluca, Adam P ^a,b   Stone, Edwin M ^a,b   Alward, Wallace L M ^a,b   Wang, Kai ^b   Fingert, John H ^a,b  

^a UNIVERSITY OF IOWA   (United States)

^b UNIVERSITY OF IOWA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; ARTICLE; COHORT ANALYSIS; CONTROLLED STUDY; EXOME; FEMALE; GENE; GENE IDENTIFICATION; GENE MUTATION; GENE SEQUENCE; HUMAN; LOW TENSION GLAUCOMA; MAJOR CLINICAL STUDY; MALE; SANGER SEQUENCING; SEQUENCE ANALYSIS; SQSTM1 GENE; GENETICS; METABOLISM; MUTATION;

OPTN PROTEIN, HUMAN; PROTEIN SERINE THREONINE KINASE; SEQUESTOSOME 1; SQSTM1 PROTEIN, HUMAN; TBK1 PROTEIN, HUMAN; TRANSCRIPTION FACTOR IIIA;

AGED; FEMALE; HUMANS; LOW TENSION GLAUCOMA; MALE; MUTATION; PROTEIN-SERINE-THREONINE KINASES; SEQUESTOSOME-1 PROTEIN; TRANSCRIPTION FACTOR TFIIIA;

EID: 84974808246     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0156001     Document Type: Article

References (45)

1. Quigley HA, Broman AT. The number of people with glaucoma worldwide in 2010 and 2020. Br J Ophthalmol. BMJ Publishing Group Ltd; 2006; 90: 262-267. doi: 10.1136/bjo.2005.081224
2. Gordon MO, Beiser JA, Brandt JD, Heuer DK, Higginbotham EJ, Johnson CA, et al. The Ocular Hypertension Treatment Study: baseline factors that predict the onset of primary open-angle glaucoma. Arch Ophthalmol. 2002; 120: 714-20- discussion 829-30. PMID: 12049575
3. Anderson DR, Drance SM, Schulzer M, Collaborative Normal-Tension Glaucoma Study Group. Natural history of normal-tension glaucoma. Ophthalmology. 2001; 108: 247-253. PMID: 11158794
4. Writing Committee for the Normal Tension Glaucoma Genetic Study Group of Japan Glaucoma Society, Meguro A, Inoko H, Ota M, Mizuki N, Bahram S. Genome-wide association study of normal tension glaucoma: common variants in SRBD1 and ELOVL5 contribute to disease susceptibility. Ophthalmology. 2010; 117: 1331-8.e5. doi: 10.1016/j.ophtha.2009.12.001 PMID: 20363506
5. Shibuya E, Meguro A, Ota M, Kashiwagi K, Mabuchi F, Iijima H, et al. Association of Toll-like receptor 4 gene polymorphisms with normal tension glaucoma. Invest Ophthalmol Vis Sci. Association for Research in Vision and Ophthalmology; 2008; 49: 4453-4457. doi: 10.1167/iovs.07-1575
6. Burdon KP, MacGregor S, Hewitt AW, Sharma S, Chidlow G, Mills RA, et al. Genome-wide association study identifies susceptibility loci for open angle glaucoma at TMCO1 and CDKN2B-AS1. Nat Genet. 2011; 43: 574-578. doi: 10.1038/ng.824 PMID: 21532571
7. Wiggs JL, Yaspan BL, Hauser MA, Kang JH, Allingham RR, Olson LM, et al. Common variants at 9p21 and 8q22 are associated with increased susceptibility to optic nerve degeneration in glaucoma. PLoS Genet. 2012; 8: e1002654. doi: 10.1371/journal.pgen.1002654 PMID: 22570617
8. Fingert JH. Primary open-angle glaucoma genes. Eye. 2011; 25: 587-595. doi: 10.1038/eye.2011.97 PMID: 21562585
9. Rezaie T, Child A, Hitchings R, Brice G, Miller L, Coca-Prados M, et al. Adult-onset primary open-angle glaucoma caused by mutations in optineurin. Science. American Association for the Advancement of Science; 2002; 295: 1077-1079. doi: 10.1126/science.1066901
10. Alward WLM, Kwon YH, Kawase K, Craig JE, Hayreh SS, Johnson AT, et al. Evaluation of optineurin sequence variations in 1,048 patients with open-angle glaucoma. Am J Ophthalmol. 2003; 136: 904-910. PMID: 14597044
11. Hauser MA, Sena DF, Flor J, Walter J, Auguste J, LaRocque-Abramson K, et al. Distribution of optineurin sequence variations in an ethnically diverse population of low-tension glaucoma patients from the United States. J Glaucoma. 2006; 15: 358-363. PMID: 16988596
12. Fingert JH, Robin AL, Roos Ben R, Davis LK, Scheetz TE, Wassink TH, et al. Copy number variations on chromosome 12q14 in patients with normal tension glaucoma. Hum Mol Genet. Oxford University Press; 2011; 20: 2482-2494. doi: 10.1093/hmg/ddr123
13. Kawase K, Allingham RR, Meguro A, Mizuki N, Roos B, Solivan-Timpe FM, et al. Confirmation of TBK1 duplication in normal tension glaucoma. Exp Eye Res. 2012; 96: 178-180. doi: 10.1016/j.exer.2011.12.021 PMID: 22306015
14. Ritch R, Darbro B, menon G, Khanna CL, Solivan-Timpe F, Roos BR, et al. TBK1 Gene Duplication and Normal-Tension Glaucoma. JAMA ophthalmology. American Medical Association; 2014; 132: 544-548. doi: 10.1001/jamaophthalmol.2014.104
15. Liu Y, Garrett ME, Yaspan BL, Bailey JC, Loomis SJ, Brilliant M, et al. DNA copy number variants of known glaucoma genes in relation to primary open-angle glaucoma. Invest Ophthalmol Vis Sci. 2014; 55: 8251-8258. doi: 10.1167/iovs.14-15712 PMID: 25414181
16. Awadalla MS, Fingert JH, Roos BE, Chen S, Holmes R, Galanopolous A, et al. Copy Number Variations of TBK1 in Australian Patients With Primary Open-Angle Glaucoma. Am J Ophthalmol. 2015; 159: 124-130.e1. doi: 10.1016/j.ajo.2014.09.044 PMID: 25284765
17. Autophagy in the pathogenesis of disease. 2008; 132: 27-42. doi: 10.1016/j.cell.2007.12.018
18. Wild P, Farhan H, McEwan DG, Wagner S, Rogov VV, Brady NR, et al. Phosphorylation of the autophagy receptor optineurin restricts Salmonella growth. Science. American Association for the Advancement of Science; 2011; 333: 228-233. doi: 10.1126/science.1205405
19. Levine B. Eating oneself and uninvited guests: autophagy-related pathways in cellular defense. Cell. 2005; 120: 159-162. doi: 10.1016/j.cell.2005.01.005 PMID: 15680321
20. Wong E, Cuervo AM. Autophagy gone awry in neurodegenerative diseases. Nat Neurosci. 2010; 13: 805-811. doi: 10.1038/nn.2575 PMID: 20581817
21. Wong YC, Holzbaur ELF. Optineurin is an autophagy receptor for damaged mitochondria in parkin-mediated mitophagy that is disrupted by an ALS-linked mutation. Proceedings of the National Academy of Sciences. National Acad Sciences; 2014; 111: E4439-48. doi: 10.1073/pnas.1405752111
22. Wong YC, Holzbaur ELF. Autophagosome dynamics in neurodegeneration at a glance. J Cell Sci. The Company of Biologists Ltd; 2015; 128: 1259-1267. doi: 10.1242/jcs.161216
23. Nixon RA. The role of autophagy in neurodegenerative disease. Nat Med. 2013; 19: 983-997. doi: 10.1038/nm.3232 PMID: 23921753
24. Nassif M, Hetz C. Targeting autophagy in ALS: a complex mission. Autophagy. 2011; 7: 450-453. PMID: 21252621
25. Park HYL, Kim JH, Park CK. Activation of autophagy induces retinal ganglion cell death in a chronic hypertensive glaucoma model. Cell Death Dis. 2012; 3: e290. doi: 10.1038/cddis.2012.26 PMID: 22476098
26. Piras A, Gianetto D, Conte D, Bosone A, Vercelli A. Activation of autophagy in a rat model of retinal ischemia following high intraocular pressure. PLoS ONE. 2011; 6: e22514. doi: 10.1371/journal.pone.0022514 PMID: 21799881
27. Morton S, Peggie M, Cohen P. Enhanced binding of TBK1 by an optineurin mutant that causes a familial form of primary open angle glaucoma. FEBS Lett. 2008; 582: 997-1002. doi: 10.1016/j.febslet.2008.02.047 PMID: 18307994
28. Tucker BA, Solivan-Timpe F, Roos BR, Anfinson KR, Robin AL, Wiley LA, et al. Duplication of TBK1 Stimulates Autophagy in iPSC-derived Retinal Cells from a Patient with Normal Tension Glaucoma. Journal of Stem cell research & therapy. 2014; 3: 161. doi: 10.4172/2157-7633.1000161
29. Pilli M, Arko-Mensah J, Ponpuak M, Roberts E, Master S, Mandell MA, et al. TBK-1 promotes autophagy-mediated antimicrobial defense by controlling autophagosome maturation. Immunity. 2012; 37: 223-234. doi: 10.1016/j.immuni.2012.04.015 PMID: 22921120
30. Cirulli ET, Lasseigne BN, Petrovski S, Sapp PC, Dion PA, Leblond CS, et al. Exome sequencing in amyotrophic lateral sclerosis identifies risk genes and pathways. Science. American Association for the Advancement of Science; 2015; 347: 1436-1441. doi: 10.1126/science.aaa3650
31. Freischmidt A, Wieland T, Richter B, Ruf W, Schaeffer V, Müller K, et al. Haploinsufficiency of TBK1 causes familial ALS and fronto-temporal dementia. Nat Neurosci. 2015; 18: 631-636. doi: 10.1038/nn.4000 PMID: 25803835
32. Maruyama H, Morino H, Ito H, Izumi Y, Kato H, Watanabe Y, et al. Mutations of optineurin in amyotrophic lateral sclerosis. Nature. 2010; 465: 223-226. doi: 10.1038/nature08971 PMID: 20428114
33. Fecto F, Yan J, Vemula SP, Liu E, Yang Y, Chen W, et al. SQSTM1 mutations in familial and sporadic amyotrophic lateral sclerosis. Arch Neurol. American Medical Association; 2011; 68: 1440-1446. doi: 10.1001/archneurol.2011.250
34. Rubino E, Rainero I, Chiò A, Rogaeva E, Galimberti D, Fenoglio P, et al. SQSTM1 mutations in fronto-temporal lobar degeneration and amyotrophic lateral sclerosis. Neurology. Lippincott Williams & Wilkins; 2012; 79: 1556-1562. doi: 10.1212/WNL.0b013e31826e25df
35. DeLuca AP, Whitmore SS, Barnes J, Sharma TP, Westfall TA, Scott CA, et al. Hypomorphic mutations in TRNT1 cause retinitis pigmentosa with erythrocytic microcytosis. Hum Mol Genet. Oxford University Press; 2016; 25: 44-56. doi: 10.1093/hmg/ddv446
36. Li H, Durbin R. Fast and accurate short read alignment with Burrows-Wheeler transform. Bioinformatics. Oxford University Press; 2009; 25: 1754-1760. doi: 10.1093/bioinformatics/btp324
37. DePristo MA, Banks E, Poplin R, Garimella KV, Maguire JR, Hartl C, et al. A framework for variation discovery and genotyping using next-generation DNA sequencing data. Nat Genet. 2011; 43: 491-498. doi: 10.1038/ng.806 PMID: 21478889
38. Tucker BA, Scheetz TE, Mullins RF, DeLuca AP, Hoffmann JM, Johnston RM, et al. Exome sequencing and analysis of induced pluripotent stem cells identify the cilia-related gene male germ cell-associated kinase (MAK) as a cause of retinitis pigmentosa. Proceedings of the National Academy of Sciences. National Acad Sciences; 2011; 108: E569-76. doi: 10.1073/pnas.1108918108
39. Exome Aggregation Consortium (ExAC) [Internet]. 1st ed. Cambridge. Available:
40. Hirano M, Nakamura Y, Saigoh K, Sakamoto H, Ueno S, Isono C, et al. Mutations in the gene encoding p62 in Japanese patients with amyotrophic lateral sclerosis. Neurology. Lippincott Williams & Wilkins; 2013; 80: 458-463. doi: 10.1212/WNL.0b013e31827f0fe5
41. Teyssou E, Takeda T, Lebon V, Boillée S, Doukouré B, Bataillon G, et al. Mutations in SQSTM1 encoding p62 in amyotrophic lateral sclerosis: genetics and neuropathology. Acta Neuropathol. Springer-Verlag; 2013; 125: 511-522. doi: 10.1007/s00401-013-1090-0
42. Shimizu H, Toyoshima Y, Shiga A, Yokoseki A, Arakawa K, Sekine Y, et al. Sporadic ALS with compound heterozygous mutations in the SQSTM1 gene. Acta Neuropathol. Springer Berlin Heidelberg; 2013; 126: 453-459. doi: 10.1007/s00401-013-1150-5
43. Le Ber I, Camuzat A, Guerreiro R, Bouya-Ahmed K, Bras J, Nicolas G, et al. SQSTM1 mutations in French patients with frontotemporal dementia or frontotemporal dementia with amyotrophic lateral sclerosis. JAMA Neurol. American Medical Association; 2013; 70: 1403-1410. doi: 10.1001/jamaneurol.2013.3849
44. Kwok CT, Morris A, de Belleroche JS. Sequestosome-1 (SQSTM1) sequence variants in ALS cases in the UK: prevalence and coexistence of SQSTM1 mutations in ALS kindred with PDB. Eur J Hum Genet. 2014; 22: 492-496. doi: 10.1038/ejhg.2013.184 PMID: 23942205
45. Yang Y, Tang L, Zhang N, Pan L, Hadano S, Fan D. Six SQSTM1 mutations in a Chinese amyotrophic lateral sclerosis cohort. Amyotroph Lateral Scler Frontotemporal Degener. 2015; 16: 378-384. doi: 10.3109/21678421.2015.1009466 PMID: 25708934